 Homology Medicines Inc NASDAQ:FIXX has been given a consensus rating of Buy by the ten analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month target price among brokers that ... 